510(k) DEN190034

Control-IQ Technology by Tandem Diabetes Care, Inc. — Product Code QJI

Clearance Details

Decision
DENG (De Novo Granted)
Decision Date
December 13, 2019
Date Received
July 15, 2019
Clearance Type
Direct
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Interoperable Automated Glycemic Controller
Device Class
Class II
Regulation Number
862.1356
Review Panel
CH
Submission Type

An interoperable automated glycemic controller is a device intended to automatically calculate drug doses based on inputs such as glucose and other relevant physiological parameters, and to command the delivery of such drug doses from a connected infusion pump. Interoperable automated glycemic controllers are designed to reliably and securely communicate with digitally connected devices to allow drug delivery commands to be sent, received, executed, and confirmed. Interoperable automated glycemic controllers are intended to be used in conjunction with digitally connected devices for the purpose of maintaining glycemic control.